Can Wegovy Cause Nosebleeds?

Is a nosebleed listed as a Wegovy side effect anywhere?

The short answer is no. The UK summary of product characteristics for Wegovy, along with the NHS semaglutide medicines page, sets out the recognised adverse reactions by frequency. The common ones are gastrointestinal: nausea tends to top the list, followed by vomiting, diarrhoea, constipation and indigestion. Headache, dizziness, fatigue and injection-site reactions also feature. Epistaxis (the clinical term for nosebleeds) does not appear in the frequency tables across any of those categories.

The STEP 1 phase-3 trial, published in the New England Journal of Medicine, randomised over 1,900 adults with obesity to semaglutide 2.4mg or placebo over 68 weeks. Nosebleeds were not flagged as a signal in that data. The same holds for the broader STEP programme. This is worth knowing, because it means a nosebleed that starts after your first Wegovy pen almost certainly has a different explanation.

If you want to read the full side-effect profile before or during treatment, our page on whether Wegovy can make you bleed goes into more detail, and the patient information leaflet inside every pen box contains the complete list.

Why might someone on Wegovy get nosebleeds?

Treatment rarely exists in a vacuum. Most people starting a weight-loss medicine are also managing other health conditions, and the coincidence of a new treatment and a new symptom doesn't always mean one caused the other.

A few plausible explanations are worth considering. First, blood pressure. Carrying excess weight often raises blood pressure, and as weight falls during Wegovy treatment, blood pressure can shift too, sometimes requiring a review of antihypertensive medication. Blood pressure fluctuations, particularly if hypertension was previously under-managed, are a common trigger for nosebleeds. Second, concurrent medicines. Anticoagulants, antiplatelet drugs (aspirin, clopidogrel), certain antidepressants and nasal corticosteroid sprays can all contribute to nosebleeds independently of semaglutide. Third, the obvious environmental ones: central heating, air conditioning, seasonal dryness and hay fever are responsible for the majority of nosebleeds in the general population.

None of this means your symptoms should be dismissed. If the nosebleeds are heavy, recurring frequently, or accompanied by bruising or unusual bleeding elsewhere, that warrants a conversation with your GP — not because Wegovy is the likely culprit, but because that pattern deserves investigation on its own terms. Our frequently asked questions cover several similar queries about symptoms people notice during treatment.

How does this compare to other side effects people ask about?

Questions about unexpected symptoms during Wegovy treatment are common, and most of them follow a similar pattern: a person notices something new, searches online, and finds it hard to distinguish a listed side effect from a coincidence. That uncertainty is reasonable. Wegovy carries a Black Triangle (▼) designation in the UK, meaning the MHRA actively monitors it for new safety signals, and healthcare professionals and patients are encouraged to report anything unusual through the Yellow Card scheme.

Some effects that do have a recognised link to semaglutide are less obvious than nausea. Gallbladder problems, for instance, are a listed risk. Pancreatitis, though infrequent, is serious enough that the MHRA reinforced guidance on it in early 2026: severe or persistent stomach pain that spreads to the back is a reason to seek urgent medical attention, not to wait and see. You can read more about the broader range of effects people ask about on our does Wegovy cause page.

Leg aches and muscle discomfort are another symptom that crops up for some people; if that's been on your mind, our page on Wegovy and achy legs works through what the evidence says. And if you're curious about how semaglutide works as a medicine before deciding whether it's right for you, our semaglutide overview covers the mechanism in plain English.

When should you contact someone about a symptom during treatment?

A single mild nosebleed is almost certainly not a reason to stop treatment or panic. Treat it the same way you would off treatment: tilt your head forward (not back), pinch the soft part of your nose and wait. Most nosebleeds stop within ten to twenty minutes.

You should speak to your prescriber or GP if nosebleeds are happening several times a week, lasting longer than 20 to 30 minutes, producing an unusually heavy flow, or arriving alongside other signs like unexplained bruising or blood in urine or stools. These are patterns that need investigation regardless of what medicines you're taking.

For anything that feels like a medical emergency (including very heavy or uncontrollable bleeding) call 999 or go to A&E. The Yellow Card scheme is the right channel for reporting a suspected side effect to the MHRA, even if you're not sure semaglutide is the cause; reporting suspected reactions is how new safety signals are caught early.

If you have questions specific to your own situation, or you're considering starting treatment in your area and want to understand what to watch for, our Wegovy service in Leeds offers individually reviewed cases with same-day clinical support. You can read more about Wegovy as a treatment, or if you're ready, speak to our prescribers through a free consultation and get a same-day clinical review.